These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34300332)

  • 21. Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks.
    Giacchi G; Ortega-Paz L; Brugaletta S; Ishida K; Sabaté M
    Postepy Kardiol Interwencyjnej; 2015; 11(3):161-9. PubMed ID: 26677353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials.
    Verdoia M; Kedhi E; Suryapranata H; Galasso G; Dudek D; De Luca G
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):813-824. PubMed ID: 31730255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Resorbable Magnesium Scaffold Magmaris in Acute Coronary Syndrome: An Appraisal of Evidence and User Group Guidance.
    Bennett J; Ielasi A; Torzewski J; de Hemptinne Q; Cerrato E; Lanocha M; Galli S; Sabaté M
    Cardiovasc Revasc Med; 2022 Jun; 39():106-113. PubMed ID: 34629285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
    Serruys PW; Chevalier B; Dudek D; Cequier A; Carrié D; Iniguez A; Dominici M; van der Schaaf RJ; Haude M; Wasungu L; Veldhof S; Peng L; Staehr P; Grundeken MJ; Ishibashi Y; Garcia-Garcia HM; Onuma Y
    Lancet; 2015 Jan; 385(9962):43-54. PubMed ID: 25230593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
    Wykrzykowska JJ; Kraak RP; Hofma SH; van der Schaaf RJ; Arkenbout EK; IJsselmuiden AJ; Elias J; van Dongen IM; Tijssen RYG; Koch KT; Baan J; Vis MM; de Winter RJ; Piek JJ; Tijssen JGP; Henriques JPS;
    N Engl J Med; 2017 Jun; 376(24):2319-2328. PubMed ID: 28402237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1.
    Anadol R; Dimitriadis Z; Polimeni A; Wendling F; Gönner S; Ullrich H; Lorenz L; Weissner M; Munzel T; Gori T
    Clin Hemorheol Microcirc; 2018; 69(1-2):3-8. PubMed ID: 29630530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.
    Masiero G; Mojoli M; Ueshima D; Tarantini G
    J Thorac Dis; 2017 Aug; 9(Suppl 9):S940-S949. PubMed ID: 28894600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
    Blachutzik F; Achenbach S; Tröbs M; Marwan M; Weissner M; Nef H; Schlundt C
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):202-207. PubMed ID: 30196573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.
    de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P
    J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.
    Byrne RA; Alfonso F; Schneider S; Maeng M; Wiebe J; Kretov E; Bradaric C; Rai H; Cuesta J; Rivero F; Hoppmann P; Schlichtenmaier J; Christiansen EH; Cassese S; Joner M; Schunkert H; Laugwitz KL; Kastrati A
    Eur Heart J; 2019 Jan; 40(2):167-176. PubMed ID: 30520980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes.
    De Rosa R; Silverio A; Varricchio A; De Luca G; Di Maio M; Radano I; Belmonte M; De Angelis MC; Moscarella E; Citro R; Piscione F; Galasso G
    Am J Cardiol; 2018 Jul; 122(1):61-68. PubMed ID: 29699747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
    Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model.
    Waksman R; Lipinski MJ; Acampado E; Cheng Q; Adams L; Torii S; Gai J; Torguson R; Hellinga DM; Westman PC; Joner M; Zumstein P; Kolodgie FD; Virmani R
    Circ Cardiovasc Interv; 2017 Aug; 10(8):. PubMed ID: 28801538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario.
    Boeder NF; Dörr O; Koepp T; Blachutzik F; Achenbach S; Elsässer A; Hamm CW; Nef HM
    Front Cardiovasc Med; 2021; 8():696287. PubMed ID: 34195239
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Brugaletta S; Cequier A; Alfonso F; Iñiguez A; Romaní S; Serra A; Salinas P; Goicolea J; Bordes P; Del Blanco BG; Hernández-Antolín R; Pernigotti A; Gómez-Lara J; Sabaté M
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):64-70. PubMed ID: 30196572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.
    Gil RJ; Bil J; Pawłowski T; Yuldashev N; Kołakowski L; Jańczak J; Jabłoński W; Paliński P
    Kardiol Pol; 2016; 74(7):627-33. PubMed ID: 26779846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions).
    Azzalini L; Giustino G; Ojeda S; Serra A; La Manna A; Ly HQ; Bellini B; Benincasa S; Chavarría J; Gheorghe LL; Longo G; Miccichè E; D'Agosta G; Picard F; Pan M; Tamburino C; Latib A; Carlino M; Chieffo A; Colombo A
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27765802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.